Zobrazeno 1 - 10
of 775
pro vyhledávání: '"Zaveri, NT"'
Autor:
Bossert JM; Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, U.S.A.. jennifer.bossert@nih.gov., Caldwell KE; Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, U.S.A., Korah H; Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, U.S.A., Batista A; Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, U.S.A., Bonbrest H; Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, U.S.A., Fredriksson I; Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, U.S.A., Jackson SN; Translational Analytical Core, IRP/NIDA/NIH, Baltimore, MD, U.S.A., Sulima A; Molecular Targets and Medications Discovery Branch, IRP/NIDA, NIAAA/NIH, Baltimore, MD, U.S.A., Rice KC; Molecular Targets and Medications Discovery Branch, IRP/NIDA, NIAAA/NIH, Baltimore, MD, U.S.A., Zaveri NT; Astraea Therapeutics, 320 Logue Avenue, Mountain View, CA, USA., Shaham Y; Behavioral Neuroscience Branch, IRP/NIDA/NIH, Baltimore, MD, U.S.A.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2024 Sep 13. Date of Electronic Publication: 2024 Sep 13.
Small molecule NOP agonists reverse locomotor sensitization induced by cocaine in male C57BL/6 mice.
Autor:
Lutfy K; College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, United States of America. Electronic address: klutfy@westernu.edu., Hamid A; College of Pharmacy, Western University of Health Sciences, Pomona, CA 91766, United States of America., Zaveri NT; Astraea Therapeutics, 320 Logue Avenue, Mountain View, CA, United States of America. Electronic address: nurulain@astraeatherapeutics.com.
Publikováno v:
Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2024 Apr 20; Vol. 131, pp. 110941. Date of Electronic Publication: 2024 Jan 09.
Autor:
D'Oliveira da Silva F; Research Center on Animal Cognition (CRCA), Center of Integrative Biology (CBI), University of Toulouse, CNRS UMR-5169, UPS, Toulouse, France., Zaveri NT; Astraea Therapeutics, 320 Logue Avenue, Mountain View, CA, USA., Moulédous L; Research Center on Animal Cognition (CRCA), Center of Integrative Biology (CBI), University of Toulouse, CNRS UMR-5169, UPS, Toulouse, France. Electronic address: lionel.mouledous@univ-tlse3.fr.
Publikováno v:
Neurobiology of learning and memory [Neurobiol Learn Mem] 2023 Nov; Vol. 205, pp. 107841. Date of Electronic Publication: 2023 Oct 11.
Autor:
Meyer ME; Astraea Therapeutics, LLC, 320 Logue Ave, Suite 142, Mountain View, CA 94043, USA., Doshi A; Astraea Therapeutics, LLC, 320 Logue Ave, Suite 142, Mountain View, CA 94043, USA., Polgar WE; Astraea Therapeutics, LLC, 320 Logue Ave, Suite 142, Mountain View, CA 94043, USA., Zaveri NT; Astraea Therapeutics, LLC, 320 Logue Ave, Suite 142, Mountain View, CA 94043, USA. Electronic address: nurulain@astraeatherapeutics.com.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2023 Sep 07; Vol. 92, pp. 117421. Date of Electronic Publication: 2023 Jul 21.
Autor:
Pisanò CA; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy., Mercatelli D; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy., Mazzocchi M; Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland., Brugnoli A; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy., Morella I; Neuroscience and Mental Health Research Institute, Division of Neuroscience, School of Biosciences, Cardiff University, Cardiff, UK., Fasano S; Neuroscience and Mental Health Research Institute, Division of Neuroscience, School of Biosciences, Cardiff University, Cardiff, UK., Zaveri NT; Astraea Therapeutics, Medicinal Chemistry Division, Mountain View, California, USA., Brambilla R; Neuroscience and Mental Health Research Institute, Division of Neuroscience, School of Biosciences, Cardiff University, Cardiff, UK.; Department of Biology and Biotechnology 'L. Spallanzani', University of Pavia, Pavia, Italy., O'Keeffe GW; Department of Anatomy and Neuroscience, University College Cork, Cork, Ireland., Neubig RR; Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan, USA., Morari M; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2023 Apr; Vol. 180 (7), pp. 927-942. Date of Electronic Publication: 2022 Jan 12.
Autor:
Meyer ME; Astraea Therapeutics, LLC, 320 Logue Avenue, Mountain View, California, 94043, USA., Doshi A; Astraea Therapeutics, LLC, 320 Logue Avenue, Mountain View, California, 94043, USA., Yasuda D; Astraea Therapeutics, LLC, 320 Logue Avenue, Mountain View, California, 94043, USA., Zaveri NT; Astraea Therapeutics, LLC, 320 Logue Avenue, Mountain View, California, 94043, USA. nurulain@astraeatherapeutics.com.
Publikováno v:
The AAPS journal [AAPS J] 2021 May 11; Vol. 23 (3), pp. 68. Date of Electronic Publication: 2021 May 11.
Autor:
Cippitelli A; Biomedical Science Department, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, United States., Barnes M; Biomedical Science Department, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, United States., Zaveri NT; Astraea Therapeutics Inc., Mountain View, CA, United States., Toll L; Biomedical Science Department, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, United States.
Publikováno v:
Addiction biology [Addict Biol] 2020 Nov; Vol. 25 (6), pp. e12844. Date of Electronic Publication: 2019 Nov 10.
Autor:
Dasgupta P; Department of Pharmacology and Toxicology, Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Drackendorfer Straße 1, 07747, Jena, Germany., Mann A; Department of Pharmacology and Toxicology, Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Drackendorfer Straße 1, 07747, Jena, Germany., Polgar WE; Astraea Therapeutics, 320 Logue Avenue, Suite 142, Mountain View, CA, 94043, USA., Reinscheid RK; Department of Pharmacology and Toxicology, Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Drackendorfer Straße 1, 07747, Jena, Germany., Zaveri NT; Astraea Therapeutics, 320 Logue Avenue, Suite 142, Mountain View, CA, 94043, USA., Schulz S; Department of Pharmacology and Toxicology, Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Drackendorfer Straße 1, 07747, Jena, Germany. Stefan.Schulz@med.uni-jena.de.
Publikováno v:
Scientific reports [Sci Rep] 2022 May 03; Vol. 12 (1), pp. 7154. Date of Electronic Publication: 2022 May 03.
Autor:
Denys IB; Department of Pharmacology and Experimental Therapeutics and the Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA., Gao J; Department of Pharmacology and Experimental Therapeutics and the Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA., Sutphen JC; Department of Pharmacology and Experimental Therapeutics and the Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA., Zaveri NT; Astraea Therapeutics, Medicinal Chemistry Division, Mountain View, California, USA., Kapusta DR; Department of Pharmacology and Experimental Therapeutics and the Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2022 Jan; Vol. 179 (2), pp. 287-300. Date of Electronic Publication: 2021 Dec 12.
Autor:
Lu JJ; Astraea Therapeutics, Mountain View, California (J.J.L., W.E.P., N.T.Z.); and Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (A.M., P.D., S.S.)., Polgar WE; Astraea Therapeutics, Mountain View, California (J.J.L., W.E.P., N.T.Z.); and Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (A.M., P.D., S.S.)., Mann A; Astraea Therapeutics, Mountain View, California (J.J.L., W.E.P., N.T.Z.); and Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (A.M., P.D., S.S.)., Dasgupta P; Astraea Therapeutics, Mountain View, California (J.J.L., W.E.P., N.T.Z.); and Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (A.M., P.D., S.S.)., Schulz S; Astraea Therapeutics, Mountain View, California (J.J.L., W.E.P., N.T.Z.); and Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (A.M., P.D., S.S.)., Zaveri NT; Astraea Therapeutics, Mountain View, California (J.J.L., W.E.P., N.T.Z.); and Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (A.M., P.D., S.S.) nurulain@astraeatherapeutics.com.
Publikováno v:
Molecular pharmacology [Mol Pharmacol] 2021 Jul; Vol. 100 (1), pp. 7-18. Date of Electronic Publication: 2021 May 06.